From: Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
Treatment groups | Completion of treatment | Tumor volume (mm3) | Tumor weight (g) | Body weight (g) | |||
---|---|---|---|---|---|---|---|
Mean | Range | Mean | Range | Mean | Range | ||
Control | 5/8a | 816 | 524–999 | 596 | 373–790 | 26 | 24–28 |
IFN-β | 7/8a | 660 | 281–1370 | 507 | 161–852 | 26 | 24–28 |
Gemcitabine | 5/7a + b | 745 | 402–1187 | 628 | 166–1121 | 25 | 24–27 |
IFN-β + gemcitabine | 6/8 | 447c | 213–572 | 492 | 161–958 | 26 | 24–28 |